Related Experiment Video
Updated: Jan 30, 2026

Visualization of Vascular and Parenchymal Regeneration after 70% Partial Hepatectomy in Normal Mice
Published on: September 13, 2016
Attempts to strengthen and simplify the tumor vascular normalization strategy using tumor vessel normalization
1State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Stability of Biopharmaceuticals, Department of Pharmaceutics, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, China.
Abstract:
Tumor vascular normalization theory opened the door for the rational use of antiangiogenic agents and chemotherapeutics. However, efforts to seize the normalization window have constrained the development of vascular normalization therapy in clinical applications owing to the lack of circulating biomarkers and the tedious dosage regimes. Applying "Occam's Razor" to therapeutic design inspired us to construct an effective and simple tumor vascular normalization prompting strategy. Herein, we developed tumor vessel normalization prompting nanomedicine lipid derivative conjugates (LGCs) made of anti-angiogenic agents with low molecular weight heparin (LMWH) and gemcitabine (Gem). This treatment exploits the complementary action of anti-vascular endothelial growth factor (VEGF) therapy and metronomic chemotherapy (MET) to strengthen the tumor vascular normalization effect. Furthermore, by loading cytotoxic drugs, such as paclitaxel (PTX), into the LGCs we constructed a "nano-community" to simultaneously restore the tumor vasculature and deliver the loaded drugs. Accordingly, improved drug delivery and therapeutic outcomes were achieved with no need to identify the precise time of the normalization window. Overall, our studies suggest that tumor vessel normalization therapy and nanomedicine design could be combined in one entity, using two waves of normalization strategies to achieve optimal chemo drug delivery into solid tumors.
Insights
This study introduces novel nanomedicine lipid derivative conjugates (LGCs) that enhance tumor vascular normalization and drug delivery. These LGCs simplify treatment by combining anti-angiogenic therapy and chemotherapy, improving outcomes without needing to time the normalization window.
Area of Science:
- Oncology
- Nanomedicine
- Vascular Biology
Background:
- Tumor vascular normalization therapy offers a rational approach for combining antiangiogenic agents and chemotherapeutics.
- Clinical application of vascular normalization therapy is hindered by a lack of biomarkers and complex dosing schedules.
Purpose of the Study:
- To develop a simplified strategy for prompting tumor vascular normalization using nanomedicine.
- To enhance the efficacy of anti-angiogenic and chemotherapeutic agents through a novel nanoconjugate design.
Main Methods:
- Development of lipid derivative conjugates (LGCs) incorporating anti-angiogenic agents, low molecular weight heparin (LMWH), and gemcitabine (Gem).
- Loading of cytotoxic drugs like paclitaxel (PTX) into LGCs to create a multifunctional nanomedicine.
- Evaluation of the combined anti-VEGF therapy and metronomic chemotherapy (MET) effect within the nanomedicine framework.
Main Results:
- The developed LGCs effectively prompted tumor vessel normalization.
- Simultaneous restoration of tumor vasculature and targeted drug delivery were achieved.
- Improved therapeutic outcomes were observed without the need for precise normalization window timing.
Conclusions:
- Combining tumor vessel normalization therapy with nanomedicine design offers a potent strategy for cancer treatment.
- The developed nanomedicine facilitates dual-action therapy, enhancing drug delivery and tumor response.
- This approach simplifies treatment protocols and improves therapeutic efficacy in solid tumors.
Related Concept Videos
Normal Stress
When a rod is under axial loading, the internal forces and corresponding stress are normal to the plane of the section, so it is termed normal stress. It's important to...
Normal Distribution
Normal and Shear Force
Applications of Normal Distribution
The heights of 15 to 18-year-old males from Chile from 1984 to 1985 followed a normal distribution. The mean height is 172.36...
Introduction to Normal Distributions
Variation: Normal Distribution, Range, and Standard Deviation

